ArticleCell2021

In vivo CRISPR screens identify the E3 ligase Cop1 as a modulator of macrophage infiltration and cancer immunotherapy target.

Xiaoqing Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.